Effects of Pulmonary Rehabilitation on Clinical Outcomes in Children With Asthma
1 other identifier
interventional
60
1 country
1
Brief Summary
Although the practice of physical activity is recommended for children with asthma, the scientific literature available so far has focused mainly on improving functional capacity and quality of life. However, the effects of pulmonary rehabilitation in this population, especially in improving the level of physical activity in daily living (PADL) and activities of daily living (ADLs) have not yet been investigated in depth. Therefore, the objective of this study is to verify the effects of pulmonary rehabilitation on PADL, ADL, and other clinical outcomes of children with asthma. For this, a randomized clinical trial will be carried out that will have 2 groups: the control group (CG), which will receive only educational sessions, and the intervention group (IG) which will participate in a pulmonary rehabilitation program with supervised aerobic training performed three times a week with sessions of 60 minutes each. The total duration of interventions in both groups will be 12 weeks. The primary outcomes of this study are PADL (assessed using a physical activity monitor - Actigraph) and ADL; however, the following will also be evaluated: lung function, functional capacity, asthma control, and quality of life. We hypothesized that the performance of regular physical activity and supervised physical exercise by individuals with asthma could positively impact health outcomes with better control of asthma symptoms, better performance in ADL and PADL, and better quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 11, 2023
CompletedFirst Posted
Study publicly available on registry
November 21, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedNovember 21, 2023
November 1, 2023
3 months
November 11, 2023
November 16, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Physical activity
Number of steps per day, time spent (in minutes and percentage of the day) in light-intensity and moderate to vigorous physical activities, measured by a triaxial activity monitor.
12 weeks from randomization
Sedentary behavior
Time spent (in minutes and percentage of the day) in sedentary activities, measured by a triaxial activity monitor.
12 weeks from randomization
The activity of daily living
Time on a specific test to evaluate activities of daily living in children
12 weeks from randomization
Secondary Outcomes (12)
Initial assessment about general characteristics and health status
12 weeks from randomization
Pulmonary Function
12 weeks from randomization
Asthma Control
12 weeks from randomization
Exacerbation and medication diary
12 weeks from randomization
Quality of life in asthma
12 weeks from randomization
- +7 more secondary outcomes
Study Arms (2)
Control group
SHAM COMPARATORSessions once a week, covering information about the pathophysiology of asthma, medication instructions, self-monitoring techniques, environmental control techniques, and prevention strategies for children, adolescents, and families. They will also receive physical activity recommendations, as well as information about the importance and benefits of being physically active and maintaining a healthy lifestyle. The sessions will feature educational and playful videos, presentations, and participants will be able to clarify their doubts about the topic addressed.
Experimental group
EXPERIMENTALRehabilitation program performed 3x/week. Each session will last 60 minutes, with a minimum interval of 24 hours, for a period of three months. The main focus of the intervention is aerobic training, which will be carried out in three stages, treadmill with a warm-up (10 minutes), load (20 minutes), and cool-down (5 minutes). With an initial intensity of 65% of the maximum load obtained in the incremental shuttle walk test (ISWT). The intensity will be gradually increased up to 115%, keeping dyspnea and fatigue values between 4 and 6, according to the modified Borg scale. In addition, we will do a circuit focused on aerobic activities, maintaining target heart rate during its performance for 20 minutes. When necessary, supplemental oxygen will be provided during training. Volunteers in this group will receive a bronchodilator dose before starting each day's session. This group will hold educational sessions as well.
Interventions
The group will receive free physiotherapy treatment with aerobic exercises, 3x/week, 60 minutes a day, lasting 3 months, in addition to educational sessions in a playful way.
Eligibility Criteria
You may qualify if:
- Age between 6 and 12 years old;
- Clinical diagnosis of asthma, established according to the criteria of the Global Initiative for Asthma (GINA);
- Absence of other lung diseases or signs and symptoms of other lung diseases;
- Absence of cognitive changes;
- Absence of signs and symptoms of gastroesophageal reflux disease and dysphagia;
- Clinical stability according to the criteria of the Global Initiative for Asthma (GINA);
You may not qualify if:
- Desire of the patient and/or the patient's family to discontinue participation in the study for any reason;
- Present some new limitations that may interfere with functionality;
- Comorbidities that prevent or contraindicate the performance of the proposed interventions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro de Pesquisa e Pós Graduação na Unopar
Londrina, Paraná, 86041-14, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vitória Puzzi, Msc
Universidade Norte do Paraná
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 11, 2023
First Posted
November 21, 2023
Study Start
December 1, 2023
Primary Completion
March 1, 2024
Study Completion
January 1, 2025
Last Updated
November 21, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share